Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.

Laith J Abu-Raddad ORCID logo ; Hiam Chemaitelly ORCID logo ; Hadi M Yassine ; Fatiha M Benslimane ; Hebah A Al Khatib ; Patrick Tang ; Joel A Malek ; Peter Coyle ; Houssein H Ayoub ; Zaina Al Kanaani ; +13 more... Einas Al Kuwari ; Andrew Jeremijenko ; Anvar Hassan Kaleeckal ; Ali Nizar Latif ; Riyazuddin Mohammad Shaik ; Hanan F Abdul Rahim ; Gheyath K Nasrallah ; Mohamed Ghaith Al Kuwari ; Hamad Eid Al Romaihi ; Mohamed H Al-Thani ; Abdullatif Al Khal ; Adeel A Butt ; Roberto Bertollini ; (2021) Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses. Journal of travel medicine, 28 (7). taab083-. ISSN 1195-1982 DOI: 10.1093/jtm/taab083
Copy

Key messages and recommendations Thispopulation-based study documentsBNT162b2vaccine protection week-by-week after the first dose. 75% of protection against infection and disease is reached 15-21 daysafter the first dose. Protection increased most rapidly against hospitalization and death and slowest against B.1.351infection.While protection of one dose beyond 21 days could not be assessed, findings support delaying the second vaccinedosein situations of limited vaccine suppliesand high incidences.
Item Type Article
Elements ID 161401
Date Deposited 10 Aug 2021 19:23

Explore Further

picture_as_pdf
Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads